{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:59:40Z","timestamp":1786996780608,"version":"build-2736575974"},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.semnephrol.2023.151405","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T20:23:00Z","timestamp":1691094180000},"page":"151405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Diet and Polycystic Kidney Disease: Nutrients, Foods, Dietary Patterns, and Implications for Practice"],"prefix":"10.1016","volume":"43","author":[{"given":"Kelly","family":"Lambert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gardos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Coolican","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Pickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoon-Ki","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Yee-Moon","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert CM","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2023.151405_bib0001","series-title":"Polycystic Kidney Disease","article-title":"Clinical trials in autosomal dominant polycystic kidney disease","author":"Yu","year":"2015"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151405_bib0002","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/ckj\/sfx071","article-title":"Practical approaches to the management of autosomal dominant polycystic kidney disease patients in the era of tolvaptan","volume":"11","author":"M\u00fcller","year":"2018","journal-title":"Clin Kidney J"},{"issue":"9981","key":"10.1016\/j.semnephrol.2023.151405_bib0003","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(15)60907-2","article-title":"Autosomal dominant polycystic kidney disease: the changing face of clinical management","volume":"385","author":"Ong","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151405_bib0004","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s10020-020-00246-3","article-title":"Autosomal dominant polycystic kidney disease and pioglitazone for its therapy: a comprehensive review with an emphasis on the molecular pathogenesis and pharmacological aspects","volume":"26","author":"Saini","year":"2020","journal-title":"Mol Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151405_bib0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"suppl 1","key":"10.1016\/j.semnephrol.2023.151405_bib0006","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000463063","article-title":"Polycystic kidney disease and the vasopressin pathway","volume":"70","author":"van Gastel","year":"2017","journal-title":"Ann Nutr Metab"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151405_bib0007","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/ki.2012.271","article-title":"A defect in vasopressin secretion in autosomal dominant polycystic kidney disease","volume":"82","author":"Bichet","year":"2012","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151405_bib0008","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151405_bib0009","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2215\/CJN.13291019","article-title":"Metabolic reprogramming in autosomal dominant polycystic kidney disease: evidence and therapeutic potential","volume":"15","author":"Nowak","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151405_bib0010","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.semnephrol.2023.151405_bib0011","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ebiom.2016.01.027","article-title":"Fatty acid oxidation is impaired in an orthologous mouse model of autosomal dominant polycystic kidney disease","volume":"5","author":"Menezes","year":"2016","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151405_bib0012","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41581-018-0051-1","article-title":"Metabolism and mitochondria in polycystic kidney disease research and therapy","volume":"14","author":"Padovano","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151405_bib0013","doi-asserted-by":"crossref","unstructured":"Torres VE, Chapman AB, Devuyst O, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367(25):2407-2418. doi:10.1056\/NEJMoa1205511","DOI":"10.1056\/NEJMoa1205511"},{"key":"10.1016\/j.semnephrol.2023.151405_bib0014","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2147\/TCRM.S286952","article-title":"Safety profile of tolvaptan in the treatment of autosomal dominant polycystic kidney disease","volume":"17","author":"Bellos","year":"2021","journal-title":"Ther Clin Risk Manag"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151405_bib0015","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s40264-015-0327-3","article-title":"Clinical pattern of tolvaptan-associated liver injury in subjects with autosomal dominant polycystic kidney disease: analysis of clinical trials database","volume":"38","author":"Watkins","year":"2015","journal-title":"Drug Safety"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151405_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-021-02472-1","article-title":"What are the information needs and concerns of individuals with polycystic kidney disease? Results of an online survey using Facebook and social listening analysis","volume":"22","author":"Ma","year":"2021","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151405_bib0017","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12882-017-0641-3","article-title":"Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease","volume":"18","author":"Tran","year":"2017","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151405_bib0018","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/ndt\/gfx327","article-title":"European ADPKD forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care: European ADPKD forum and multispecialist roundtable participants","volume":"33","author":"Harris","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151405_bib0019","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.semnephrol.2015.10.008","article-title":"KHA-CARI autosomal dominant polycystic kidney disease guideline: diet and lifestyle management","volume":"35","author":"Campbell","year":"2015","journal-title":"Semin Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151405_bib0020","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/nep.12579","article-title":"Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney disease","volume":"21","author":"Tong","year":"2016","journal-title":"Nephrology (Carlton)"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151405_bib0021","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/MNH.0000000000000734","article-title":"Emerging non-pharmacological interventions in ADPKD: an update on dietary advices for clinical practice","volume":"30","author":"Meijer","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151405_bib0022","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ki.2013.23","article-title":"The medicinal use of water in renal disease","volume":"84","author":"Wang","year":"2013","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151405_bib0023","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/advances\/nmab131","article-title":"Dietary interventions in autosomal dominant polycystic kidney disease","volume":"13","author":"Pickel","year":"2021","journal-title":"Adv Nutr"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151405_bib0024","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3390\/nu11071576","article-title":"Dietary care for ADPKD patients: current status and future directions","volume":"11","author":"Carriazo","year":"2019","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151405_bib0025","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/nure.12085","article-title":"Evidence for a role of proteins, lipids, and phytochemicals in the prevention of polycystic kidney disease progression and severity","volume":"71","author":"Maditz","year":"2013","journal-title":"Nutr Rev"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151405_bib0026","article-title":"Prescribed water intake in autosomal dominant polycystic kidney disease","volume":"1","author":"Rangan","year":"2022","journal-title":"N Engl J Med Evid"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151405_bib0027","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.kint.2016.10.018","article-title":"Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease","volume":"91","author":"Torres","year":"2017","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151405_bib0028","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.kint.2020.04.053","article-title":"Salt, but not protein intake, is associated with accelerated disease progression in autosomal dominant polycystic kidney disease","volume":"98","author":"Kramers","year":"2020","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151405_bib0029","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11255-020-02384-3","article-title":"Sodium and urea excretion as determinants of urine output in autosomal dominant polycystic kidney disease patients on V2 receptor antagonists: impact of dietary intervention","volume":"52","author":"C\u00f4t\u00e9","year":"2020","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151405_bib0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2215\/CJN.04310709","article-title":"The HALT polycystic kidney disease trials: design and implementation","volume":"5","author":"Chapman","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151405_bib0031","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2215\/CJN.03250410","article-title":"Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease","volume":"6","author":"Torres","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151405_bib0032","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/01.hjh.0000222765.30348.0d","article-title":"The effect of sodium and angiotensin-converting enzyme inhibition on the classic circulating renin-angiotensin system in autosomal-dominant polycystic kidney disease patients","volume":"24","author":"Doulton","year":"2006","journal-title":"J Hypertens"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151405_bib0033","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00004872-199003000-00010","article-title":"Natriuresis-pressure relationship in polycystic kidney disease","volume":"8","author":"Schmid","year":"1990","journal-title":"J Hypertens"},{"issue":"18","key":"10.1016\/j.semnephrol.2023.151405_bib0034","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1056\/NEJMra1700312","article-title":"Nutritional management of chronic kidney disease","volume":"377","author":"Kalantar-Zadeh","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151405_bib0035","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1681\/ASN.V5122037","article-title":"Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group","volume":"5","author":"Klahr","year":"1995","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151405_bib0036","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1681\/ASN.V661634","article-title":"Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease","volume":"6","author":"Choukroun","year":"1995","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151405_bib0037","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1523-1755.2001.00465.x","article-title":"Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats","volume":"59","author":"Aukema","year":"2001","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151405_bib0038","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/mnfr.201000558","article-title":"Distinctive effects of plant protein sources on renal disease progression and associated cardiac hypertrophy in experimental kidney disease","volume":"55","author":"Aukema","year":"2011","journal-title":"Mol Nutr Food Res"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151405_bib0039","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/jn\/134.6.1504","article-title":"Dietary soy protein attenuates renal disease progression after 1 and 3 weeks in Han:SPRD-cy weanling rats","volume":"134","author":"Fair","year":"2004","journal-title":"J Nutr"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151405_bib0040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1523-1755.2000.00835.x","article-title":"Bankovic-Calic N. Modification of polycystic kidney disease and fatty acid status by soy protein diet","volume":"57","author":"Ogborn","year":"2000","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151405_bib0041","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3181\/0811-RM-315","article-title":"Dietary soy protein selectively reduces renal prostanoids and cyclooxygenases in polycystic kidney disease","volume":"234","author":"Peng","year":"2009","journal-title":"Exp Biol Med"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151405_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155790","article-title":"Lack of benefit of early intervention with dietary flax and fish oil and soy protein in orthologous rodent models of human hereditary polycystic kidney disease","volume":"11","author":"Yamaguchi","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151405_bib0043","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s11745-002-1001-4","article-title":"Dietary flax oil reduces renal injury, oxidized LDL content, and tissue n-6\/n-3 FA ratio in experimental polycystic kidney disease","volume":"37","author":"Ogborn","year":"2002","journal-title":"Lipids"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151405_bib0044","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s11745-006-5064-z","article-title":"Effects of flaxseed derivatives in experimental polycystic kidney disease vary with animal gender","volume":"41","author":"Ogborn","year":"2006","journal-title":"Lipids"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151405_bib0045","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1159\/000104836","article-title":"Late dietary intervention limits benefits of soy protein or flax oil in experimental polycystic kidney disease","volume":"106","author":"Sankaran","year":"2007","journal-title":"Nephron Exp Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151405_bib0046","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jn\/133.1.180","article-title":"Detrimental effects of a high fat diet in early renal injury are ameliorated by fish oil in Han:SPRD-cy rats","volume":"133","author":"Lu","year":"2003","journal-title":"J Nutr"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151405_bib0047","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/ndt\/gfn144","article-title":"The effect of eicosapentaenoic acid on renal function and volume in patients with ADPKD","volume":"23","author":"Higashihara","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2023.151405_bib0048","series-title":"Nutrient Reference Values for Australia and New Zealand","year":"2006"},{"key":"10.1016\/j.semnephrol.2023.151405_bib0049","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fmed.2019.00112","article-title":"Association of vitamin D levels with kidney volume in autosomal dominant polycystic kidney disease (ADPKD)","volume":"6","author":"Vendramini","year":"2019","journal-title":"Front Med"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151405_bib0050","doi-asserted-by":"crossref","first-page":"F574","DOI":"10.1152\/ajprenal.00411.2012","article-title":"Chronic effects of dietary vitamin D deficiency without increased calcium supplementation on the progression of experimental polycystic kidney disease","volume":"305","author":"Rangan","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2023.151405_bib0051","first-page":"24.","article-title":"Effects of cholecalciferol supplementation in autosomal dominant polycystic kidney disease (ADPKD) patients","author":"Vendramini","year":"2021","journal-title":"Hum Nutr Metab"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151405_bib0052","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bbadis.2010.11.005","article-title":"Cyclic AMP-mediated cyst expansion","volume":"1812","author":"Wallace","year":"2011","journal-title":"Biochim Biophys Acta."},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151405_bib0053","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1097\/01.ASN.0000025282.48298.7B","article-title":"The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease","volume":"13","author":"Belibi","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151405_bib0054","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1590\/S0100-879X2012007500120","article-title":"Caffeine intake by patients with autosomal dominant polycystic kidney disease","volume":"45","author":"Vendramini","year":"2012","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.semnephrol.2023.151405_bib0055","first-page":"119","article-title":"Nephrolithiasis in polycystic kidney disease: risk factors, treatment and prevention","author":"Idrizi","year":"2015","journal-title":"Nephrolithiasis: Risk Factors, Treatment and Prevention"},{"key":"10.1016\/j.semnephrol.2023.151405_bib0056","first-page":"497","article-title":"Prevalence of nephrolithiasis in polycystic kidney disease","volume":"6","author":"Idrizi","year":"2011","journal-title":"Cent Eur J Med"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151405_bib0057","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0272-6386(12)80922-X","article-title":"Renal stone disease in autosomal dominant polycystic kidney disease","volume":"22","author":"Torres","year":"1993","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151405_bib0058","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1172\/JCI128503","article-title":"Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease","volume":"129","author":"Torres","year":"2019","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151405_bib0059","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11255-021-02953-0","article-title":"Urinary citrate as a marker of renal function in patients with autosomal dominant polycystic kidney disease","volume":"54","author":"Borrego Utiel","year":"2022","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151405_bib0060","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/end.2007.0304","article-title":"Quantitative assessment of citric acid in lemon juice, lime juice, and commercially-available fruit juice products","volume":"22","author":"Penniston","year":"2008","journal-title":"J Endourol"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151405_bib0061","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00240-008-0152-6","article-title":"Can lemon juice be an alternative to potassium citrate in the treatment of urinary calcium stones in patients with hypocitraturia? A prospective randomized study","volume":"36","author":"Aras","year":"2008","journal-title":"Urol Res"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151405_bib0062","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2215\/CJN.00790209","article-title":"A case for water in the treatment of polycystic kidney disease","volume":"4","author":"Torres","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151405_bib0063","series-title":"Herbal Medicine: Biomolecular and Clinical Aspects","article-title":"Turmeric, the golden spice: from traditional medicine to modern medicine","author":"Prasad S","year":"2011"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151405_bib0064","doi-asserted-by":"crossref","first-page":"F1193","DOI":"10.1152\/ajprenal.00419.2010","article-title":"Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model","volume":"300","author":"Leonhard","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151405_bib0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/NT.0000000000000094","article-title":"Stevia, nature's zero-calorie sustainable sweetener: a new player in the fight against obesity","volume":"50","author":"Ashwell","year":"2015","journal-title":"Nutr Today"},{"issue":"1)","key":"10.1016\/j.semnephrol.2023.151405_bib0066","first-page":"S97","article-title":"Nutraceutical for autosomal dominant polycystic kidney disease therapy","volume":"99","author":"Yuajit","year":"2016","journal-title":"J Med Assoc Thai"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151405_bib0067","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bcp.2014.01.038","article-title":"Steviol retards renal cyst growth through reduction of CFTR expression and inhibition of epithelial cell proliferation in a mouse model of polycystic kidney disease","volume":"88","author":"Yuajit","year":"2014","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151405_bib0068","doi-asserted-by":"crossref","first-page":"e58871","DOI":"10.1371\/journal.pone.0058871","article-title":"Steviol reduces MDCK cyst formation and growth by inhibiting CFTR channel activity and promoting proteasome-mediated CFTR degradation","volume":"8","author":"Yuajit","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151405_bib0069","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3945\/an.115.011718","article-title":"Foods, nutrients, and dietary patterns: interconnections and implications for dietary guidelines","volume":"7","author":"Tapsell","year":"2016","journal-title":"Adv Nutr"},{"issue":"22","key":"10.1016\/j.semnephrol.2023.151405_bib0070","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1080\/10408398.2018.1502743","article-title":"The food matrix: implications in processing, nutrition and health","volume":"59","author":"Aguilera","year":"2019","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151405_bib0071","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.clnu.2016.01.003","article-title":"Diet and polycystic kidney disease: a pilot intervention study","volume":"36","author":"Taylor","year":"2017","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151405_bib0072","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0272-6386(96)90525-9","article-title":"Modification of disease progression in rats with inherited polycystic kidney disease","volume":"27","author":"Cowley","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"3 suppl 1","key":"10.1016\/j.semnephrol.2023.151405_bib0073","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","article-title":"KDOQI clinical practice guideline for nutrition in CKD: 2020 update","volume":"76","author":"Ikizler","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2023.151405_bib0074","doi-asserted-by":"crossref","unstructured":"Kelly JT, Palmer SC, Wai SN, et al. Healthy dietary patterns and risk of mortality and ESRD in CKD: a meta-analysis of cohort studies. Clin J Am Soc Nephrol. 2017;12(2):272-279.","DOI":"10.2215\/CJN.06190616"},{"key":"10.1016\/j.semnephrol.2023.151405_bib0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nutres.2021.07.006","article-title":"Greater adherence to the dietary approaches to stop hypertension dietary pattern is associated with preserved muscle strength in patients with autosomal dominant polycystic kidney disease: a single-center cross-sectional study","volume":"93","author":"Ryu","year":"2021","journal-title":"Nutr Res"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151405_bib0076","doi-asserted-by":"crossref","first-page":"F726","DOI":"10.1152\/ajprenal.00551.2015","article-title":"A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease","volume":"310","author":"Kipp","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151405_bib0077","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.2015020132","article-title":"Food restriction ameliorates the development of polycystic kidney disease","volume":"27","author":"Warner","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151405_bib0078","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5414\/CN109102","article-title":"Effects of fasting during the month of Ramadan on renal function in patients with autosomal dominant polycystic kidney disease","volume":"89","author":"Ekinci","year":"2018","journal-title":"Clin Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151405_bib0079","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.cmet.2019.09.012","article-title":"Ketosis ameliorates renal cyst growth in polycystic kidney disease","volume":"30","author":"Torres","year":"2019","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151405_bib0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/kidneydial2020020","article-title":"Ren.Nu, a dietary program for individuals with autosomal-dominant polycystic kidney disease implementing a sustainable, plant-focused, kidney-safe, ketogenic approach with avoidance of renal stressors","volume":"2","author":"Bruen","year":"2022","journal-title":"Kidney Dial"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151405_bib0081","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/ckj\/sfab162","article-title":"Ketogenic dietary interventions in autosomal dominant polycystic kidney disease\u2014a retrospective case series study: first insights into feasibility, safety and effects","volume":"15","author":"Strubl","year":"2022","journal-title":"Clin Kidney J"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151405_bib0082","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/ndt\/gfac311","article-title":"RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease","volume":"38","author":"Oehm","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151405_bib0083","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/ckj\/sfac103","article-title":"Can ketogenic dietary interventions slow disease progression in ADPKD: what we know and what we don't","volume":"15","author":"Ong","year":"2022","journal-title":"Clin Kidney J"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151405_bib0084","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161043","article-title":"Experiences and perspectives of polycystic kidney disease patients following a diet of reduced osmoles, protein, and acid precursors supplemented with water: a qualitative study","volume":"11","author":"Taylor","year":"2016","journal-title":"PLoS One"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929523001158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929523001158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T23:41:03Z","timestamp":1759448463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929523001158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0270929523001158"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151405","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diet and Polycystic Kidney Disease: Nutrients, Foods, Dietary Patterns, and Implications for Practice","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151405"}}